Feasibility of optical coherence tomography in children with Kawasaki disease and pediatric heart transplant recipients

Circulation: Cardiovascular Imaging

Volumn 7, Issue 4, 2014, Pages 671-678

  Harris, Kevin C ^a   Manouzi, Anas ^a   Fung, Anthony Y ^b   De Souza, Astrid ^a   Bezerra, Hiram G ^c   Potts, James E ^a   Hosking, Martin C K ^a  

^a Division of Pediatric Cardiology   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary disease; Heart transplantation; Kawasaki disease; Pediatrics

Indexed keywords

CORONARY DISEASE; HEART TRANSPLANTATION; KAWASAKI DISEASE; PEDIATRICS;

ADOLESCENT; CARDIAC CATHETERIZATION; CHILD; CHILD, PRESCHOOL; CORONARY ANGIOGRAPHY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84905864682     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.001764     Document Type: Article

References (29)

1. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudek D, Dudeck D, Falk E, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Garcia H, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CC, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, Räber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PW, Shimada K, Shinke T, Shite J, Siegel E, Sonoda S, Sonada S, Suter M, Takarada S, Tanaka A, Terashima M, Thim T, Troels T, Uemura S, Ughi GJ, van Beusekom HM, van der Steen AF, van Es GA, van Es GA, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G; International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT). Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol. 2012;59:1058-1072.
2. Brezinski ME, Tearney GJ, Bouma BE, Izatt JA, Hee MR, Swanson EA, Southern JF, Fujimoto JG. Optical coherence tomography for optical biopsy. Properties and demonstration of vascular pathology. Circulation. 1996;93:1206-1213.
3. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Neishi Y, Sukmawan R, Sadahira Y, Yoshida K. Assessment of coronary intima-media thickness by optical coherence tomography: comparison with intra-vascular ultrasound. Circ J. 2005;69:903-907.
4. Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopa-thy-2010. J Heart Lung Transplant. 2010;29:717-727.
5. Hathout E, Beeson WL, Kuhn M, Johnston J, Fitts J, Razzouk A, Bailey L, Chinnock RE. Cardiac allograft vasculopathy in pediatric heart transplant recipients. Transpl Int. 2006;19:184-189.
6. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385.
7. Pesonen E. Infection and intimal thickening: evidence from coronary arteries in children. Eur Heart J. 1994;15(suppl C):57-61.
8. Pesonen E. Coronary wall thickening in children. An analysis of the factors associated with the growth of arterial layers. Atherosclerosis. 1974;20:173-187.
9. Khandhar SJ, Yamamoto H, Teuteberg JJ, Shullo MA, Bezerra HG, Costa MA, Selzer F, Lee JS, Marroquin OC, McNamara DM, Mulukutla SR, Toma C. Optical coherence tomography for characterization of cardiac al-lograft vasculopathy after heart transplantation (OCTCAV study). J Heart Lung Transplant. 2013;32:596-602.
10. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, Akasaka T, Costa M, Guagliumi G, Grube E, Ozaki Y, Pinto F, Serruys PW; Expert's OCT Review Document. Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J. 2010;31:401-415.
11. Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, Nakazawa M. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation. 2000;101:2935-2941.
12. Takahashi K, Oharaseki T, Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol. 2001;22:138-142.
13. Takahashi K, Oharaseki T, Yokouchi Y, Naoe S, Saji T. Kawasaki disease: basic and pathological fndings. Clin Exp Nephrol. 2013;17:690-693.
14. Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y. Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int. 2005;47:305-310.
15. Sasaguri Y, Kato H. Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr. 1982;100:225-231.
16. Biezeveld MH, van Mierlo G, Lutter R, Kuipers IM, Dekker T, Hack CE, Newburger JW, Kuijpers TW. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloprotein-ases. Clin Exp Immunol. 2005;141:183-188.
17. Dhillon R, Clarkson P, Donald AE, Powe AJ, Nash M, Novelli V, Dillon MJ, Deanfeld JE. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996;94:2103-2106.
18. Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001;107:1095-1099.
19. Kato H. Cardiovascular complications in Kawasaki disease: coronary artery lumen and long-term consequences. Prog Pediatr Cardiol. 2004;19:137-145.
20. Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, Kudo Y, Itoh S, Ishii H, Ueno T, Tashiro T, Nobuyoshi M, Kato H, Matsuishi T. Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation. 2011;123:1836-1842.
21. Bailey LL, Zuppan CW, Chinnock RE, Johnston JK, Razzouk AJ, Gundry SR. Graft vasculopathy among recipients of heart transplantation during the frst 12 years of life. The Pediatric Heart Transplant Group. Transplant Proc. 1995;27:1921-1925.
22. Pahl E, Fricker FJ, Armitage J, Griffth BP, Taylor S, Uretsky BF, Beerman LB, Zuberbuhler JR. Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediatr. 1990;116:177-183.
23. Zuppan CW, Wells LM, Kerstetter JC, Johnston JK, Bailey LL, Chinnock RE. Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort. J Heart Lung Transplant. 2009;28:579-584.
24. Pahl E, Zales VR, Fricker FJ, Addonizio LJ. Posttransplant coronary artery disease in children. A multicenter national survey. Circulation. 1994;90(5, Part 2):II56-II60.
25. Loar RW, Driscoll DJ, Kushwaha SS, Cramer CH, O'Leary PW, Daly RC, Mauriello DA, Johnson JN. Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients. Pediatr Transplant. 2013;17:794-799.
26. Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, Magyar WA, Hobbs RE, Starling RC, Young JB, McCarthy P, Nissen SE. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol. 2005;45:1538-1542.
27. Lu WH, Palatnik K, Fishbein GA, Lai C, Levi DS, Perens G, Alejos J, Kobashigawa J, Fishbein MC. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. J Heart Lung Transplant. 2011;30:1044-1050.
28. Kobashigawa JA, Pauly DF, Starling RC, Eisen H, Ross H, Wang SS, Cantin B, Hill JA, Lopez P, Dong G, Nicholls SJ; A2310 IVUS Substudy Investigators. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus my-cophenolate mofetil randomized, multicenter trial. JACC Heart Fail. 2013;1:389-399.
29. Garrido I P, García-Lara J, Pinar E, Pastor-Pérez F, Sánchez-Mas J, Valdés-Chavarri M, Pascual-Figal DA. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy. Am J Cardiol. 2012;110:655-661.